Results 151 to 160 of about 614,692 (224)

Viral hemorrhagic fevers (continued) (Week 18) Weekly cases of notifiable diseases United States U.S. territories and Non-U.S. Residents week ending May 7, 2022

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core  

Prevalence of MRSA Bacteremia and Predictors of In‐Hospital Mortality Among Critically Ill Adults in a Tanzanian Intensive Care Unit: A Retrospective Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background and Aims Methicillin‐resistant Staphylococcus aureus bacteremia is associated with high morbidity and mortality in critically ill patients. Management is challenging due to delays in initiating effective therapy, leading to sepsis and septic shock.
Andrew M. Bombo, Abid M. Sadiq, Anthon G. Mwingwa, Elieshiupendo M. Niccodem   +3 more
wiley   +1 more source

CRISPR-Based Detection of Viral Hemorrhagic Fevers at the Point of Care. [PDF]

Viruses
Wupori K, Garnett L, Bello A, Strong JE.
europepmc   +1 more source

Viral hemorrhagic fevers: (Week 13) Weekly cases* of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents week ending April 3, 2021

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core  

Allogeneic Hematopoietic Stem Cell Transplantation Achieves Durable Remission in Blast‐Phase Chronic Myeloid Leukemia Presenting as Early T‐Cell Precursor Acute Lymphoblastic Leukemia

eJHaem, Volume 7, Issue 5, October 2026.
ABSTRACT Introduction The presentation of chronic myeloid leukemia (CML) in the blast phase as early T‐cell precursor acute lymphoblastic leukemia (ETP‐ALL) is very rare. As previously reported, in contrast to B‐ALL, the prognosis is poor. Case Presentation We encountered a patient with blast phase CML presenting as ETP‐ALL.
Takafumi Tsushima, Yukiko Konishi, Natsumi Yoda, Koichiro Wada, Kento Okamoto, Kosuke Matsuo, Shuntaro Isogai, Sonoko Shimoji, Yoshikazu Utsu, Shin‐Ichi Masuda, Nobuyuki Aotsuka   +10 more
wiley   +1 more source

Achievements and Challenges in Therapy and Vaccines Development of Viral Hemorrhagic Fevers: An Up-to-Date Review. [PDF]

Pharmaceutics
Lupascu D, Iacob AT, Apotrosoaei M, Vasincu IM, Lupascu FG, Chirliu OM, Profire BS, Tauser RG, Profire L.   +8 more
europepmc   +1 more source

Viral hemorrhagic fevers: (Week 48) Weekly cases* of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents week ending December 4, 2021

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core  

Mucosal‐Associated Invariant T Cells in Health and Disease

MedComm, Volume 7, Issue 10, October 2026.
The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao, Feng‐Mi Ou, Dan Liang, Yang Gao, Qing‐Qing Li, Yi‐Qun Kuang   +5 more
wiley   +1 more source

Viral hemorrhagic fevers (continued) (Week 37) Weekly cases of notifiable diseases United States U.S. territories and Non-U.S. Residents week ending September 12, 2020

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core   +1 more source

Ebola Virus Disease: Uniquely Challenging Among the Viral Hemorrhagic Fevers. [PDF]

Open Forum Infect Dis
Matson MJ, Chertow DS, Munster VJ.
europepmc   +1 more source